Deepti Gurdasani. (2022, January 30). Have tried to now visually illustrate an earlier thread I wrote about why prevalence estimates based on comparisons of “any symptom” between infected cases, and matched controls will yield underestimates for long COVID. I’ve done a toy example below here, to show this 🧵 [Tweet]. @dgurdasani1. https://twitter.com/dgurdasani1/status/1487578265187405828

Meaghan Kall. (2021, November 15). There are 2 other impressive conclusions from this study: 1. Comparing vaccine effectiveness of booster vs “fully vaxxed” as the baseline. Booster ADDS 81-85% protection against symptomatic infection ON TOP of what you already had from your primary (2-dose) vaccination https://t.co/5EO7m6GHTZ [Tweet]. @kallmemeg. https://twitter.com/kallmemeg/status/1460207567070769156

Andrew Wilshere was working on content at Designlab when he asked me to write an article about the Bauhaus.

I ended up writing something that never got published with Designlab. Instead, it was shared by the Bauhaus Movement to their Facebook followers.

Seow, J., Graham, C., Merrick, B., Acors, S., Steel, K. J. A., Hemmings, O., O’Bryne, A., Kouphou, N., Pickering, S., Galao, R., Betancor, G., Wilson, H. D., Signell, A. W., Winstone, H., Kerridge, C., Temperton, N., Snell, L., Bisnauthsing, K., Moore, A., … Doores, K. (2020). Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. MedRxiv, 2020.07.09.20148429. https://doi.org/10.1101/2020.07.09.20148429